inflammatory bowel disease

Innovative Partnership: AstraZeneca and Quell Therapeutics Targeting Autoimmune Diseases with Engineered Treg Cell Therapies

(IN BRIEF) AstraZeneca and Quell Therapeutics have announced a collaboration to develop innovative treatments for Type 1 Diabetes and Inflammatory…

11 months ago

Milestone for the diagnosis of inflammatory bowel disease

Clinicians at the University Hospital Erlangen show how a new laser-based imaging technique termed MSOT can detect inflammation more accurately…

7 years ago